• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒样颗粒用于癌症疫苗接种。

Virus-like particles for vaccination against cancer.

机构信息

The Interim Translational Research Institute "iTRI", National Center for Cancer Care & Research (NCCCR), Doha, Qatar.

Department of BioMedical Research, Immunology RIA, University of Bern, Bern, Switzerland.

出版信息

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Jan;12(1):e1579. doi: 10.1002/wnan.1579. Epub 2019 Aug 27.

DOI:10.1002/wnan.1579
PMID:31456339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6916610/
Abstract

Active immunotherapy of cancer aims to treat the disease by inducing effective cellular and humoral immune responses. Virus-like particle-based vaccines have evolved dramatically over the last few decades, greatly reducing morbidity and mortality of several infectious diseases and expectedly preventing cervical cancer caused by human papilloma virus. In contrast to these broad successes of disease prevention, therapeutic cancer vaccines remain to demonstrate clinical benefit. Yet, several preclinical and clinical trials have revealed promising results and are paving the way for medical breakthroughs. This study reviews and discusses the recent preclinical development and clinical trials in this field. This article is categorized under: Biology-Inspired Nanomaterials > Protein and Virus-Based Structures Nanotechnology Approaches to Biology > Nanoscale Systems in Biology.

摘要

癌症的主动免疫疗法旨在通过诱导有效的细胞和体液免疫反应来治疗疾病。过去几十年中,基于病毒样颗粒的疫苗得到了迅猛发展,大大降低了几种传染病的发病率和死亡率,并有望预防人乳头瘤病毒引起的宫颈癌。与这些广泛的疾病预防成功形成鲜明对比的是,治疗性癌症疫苗仍有待证明其临床获益。然而,一些临床前和临床试验已经显示出了有希望的结果,并为医学突破铺平了道路。本研究综述和讨论了该领域的近期临床前开发和临床试验。本文属于以下分类:生物启发的纳米材料 > 基于蛋白质和病毒的结构 纳米技术在生物学中的应用 > 生物学中的纳米级系统。

相似文献

1
Virus-like particles for vaccination against cancer.病毒样颗粒用于癌症疫苗接种。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Jan;12(1):e1579. doi: 10.1002/wnan.1579. Epub 2019 Aug 27.
2
A Bivalent, Spherical Virus-Like Particle Vaccine Enhances Breadth of Immune Responses against Pathogenic Ebola Viruses in Rhesus Macaques.双价、球形病毒样颗粒疫苗增强恒河猴对致病性埃博拉病毒免疫反应的广度。
J Virol. 2020 Apr 16;94(9). doi: 10.1128/JVI.01884-19.
3
Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer.基于重组 MS2 病毒样颗粒的信使 RNA 疫苗防治前列腺癌。
Int J Cancer. 2014 Apr 1;134(7):1683-94. doi: 10.1002/ijc.28482. Epub 2013 Oct 8.
4
Biogenic nanoparticles as immunomodulator for tumor treatment.生物成因纳米颗粒作为肿瘤治疗的免疫调节剂。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Nov;12(6):e1646. doi: 10.1002/wnan.1646. Epub 2020 May 28.
5
The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference.第五届病毒样颗粒和纳米颗粒疫苗(VLPNPV)会议。
Expert Rev Vaccines. 2019 Jan;18(1):1-3. doi: 10.1080/14760584.2019.1557522. Epub 2018 Dec 13.
6
A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.基于病毒样颗粒的手足口病四价疫苗可诱导广泛而均衡的保护性免疫。
Emerg Microbes Infect. 2018 May 18;7(1):94. doi: 10.1038/s41426-018-0094-1.
7
Virus-like particles as vaccine.病毒样颗粒作为疫苗。
Acta Biochim Pol. 2014;61(3):531-9. Epub 2014 Sep 18.
8
VLPs and particle strategies for cancer vaccines.病毒样颗粒和粒子策略在癌症疫苗中的应用。
Expert Rev Vaccines. 2013 Oct;12(10):1173-93. doi: 10.1586/14760584.2013.836909.
9
Major findings and recent advances in virus-like particle (VLP)-based vaccines.病毒样颗粒(VLP)疫苗的主要发现和最新进展。
Semin Immunol. 2017 Dec;34:123-132. doi: 10.1016/j.smim.2017.08.014. Epub 2017 Sep 5.
10
Current status and future directions of fish vaccines employing virus-like particles.鱼类病毒样颗粒疫苗的现状和未来发展方向。
Fish Shellfish Immunol. 2020 May;100:49-57. doi: 10.1016/j.fsi.2020.02.060. Epub 2020 Mar 1.

引用本文的文献

1
Therapeutic Colorectal Cancer Vaccines: Emerging Modalities and Translational Opportunities.治疗性结直肠癌疫苗:新兴模式与转化机遇
Vaccines (Basel). 2025 Jun 26;13(7):689. doi: 10.3390/vaccines13070689.
2
Advances in cancer nanovaccines: a focus on colorectal cancer.癌症纳米疫苗的进展:聚焦于结直肠癌
Nanomedicine (Lond). 2025 May;20(9):1029-1041. doi: 10.1080/17435889.2025.2486930. Epub 2025 Apr 5.
3
Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma.

本文引用的文献

1
Type of RNA Packed in VLPs Impacts IgG Class Switching-Implications for an Influenza Vaccine Design.包装在病毒样颗粒中的RNA类型影响IgG类别转换——对流感疫苗设计的启示。
Vaccines (Basel). 2019 Jun 4;7(2):47. doi: 10.3390/vaccines7020047.
2
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine.靶向突变加种系表位赋予即时形成的癌症纳米疫苗的临床前疗效。
Front Immunol. 2019 May 15;10:1015. doi: 10.3389/fimmu.2019.01015. eCollection 2019.
3
Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.
通过一种基于创新型cVLP的疫苗靶向前蛋白转化酶枯草溶菌素9(PCSK9),增强了cVLP-人表皮生长因子受体2(HER2)疫苗在HER2阳性乳腺癌临床前模型中的治疗活性。
J Transl Med. 2025 Jan 30;23(1):136. doi: 10.1186/s12967-025-06126-w.
4
Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response.病毒样颗粒:一种递送癌症抗原以引发抗肿瘤免疫反应的纳米平台。
Front Immunol. 2025 Jan 7;15:1504124. doi: 10.3389/fimmu.2024.1504124. eCollection 2024.
5
mRNA vaccines as cancer therapies.信使核糖核酸疫苗作为癌症治疗方法。
Chin Med J (Engl). 2024 Dec 20;137(24):2979-2995. doi: 10.1097/CM9.0000000000003455. Epub 2024 Dec 13.
6
Tumor Antigen-Tethered Spiked Virus-Like- Poly(Lactic-Co-Glycolic Acid)-Nanoparticle Vaccine Enhances Antitumor Ability Through Th9 Promotion in Mice.肿瘤抗原偶联刺突病毒样聚(乳酸-共-乙醇酸)-纳米颗粒疫苗通过促进 Th9 细胞在小鼠中增强抗肿瘤能力。
Int J Nanomedicine. 2024 Oct 30;19:10983-11002. doi: 10.2147/IJN.S476715. eCollection 2024.
7
Nanomedicine Therapies for Pediatric Diseases.儿科疾病的纳米医学疗法。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Sep-Oct;16(5):e1996. doi: 10.1002/wnan.1996.
8
Self-Assembly of Polymers and Their Applications in the Fields of Biomedicine and Materials.聚合物的自组装及其在生物医学和材料领域的应用。
Polymers (Basel). 2024 Jul 23;16(15):2097. doi: 10.3390/polym16152097.
9
Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response.确定高效B细胞反应的关键驱动因素:关于T辅助、抗原组织和Toll样受体刺激在产生中和性抗登革病毒反应中的作用
Vaccines (Basel). 2024 Jun 14;12(6):661. doi: 10.3390/vaccines12060661.
10
Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy.重新定义结直肠癌之战:新兴免疫疗法及其临床疗效的全面综述。
Front Immunol. 2024 Mar 12;15:1350208. doi: 10.3389/fimmu.2024.1350208. eCollection 2024.
纳米颗粒与微佐剂联合疫苗接种可预防癌症。
J Immunother Cancer. 2019 Apr 26;7(1):114. doi: 10.1186/s40425-019-0587-z.
4
Recent success and limitations of immune checkpoint inhibitors for cancer: a lesson from melanoma.免疫检查点抑制剂治疗癌症的近期成功与局限:来自黑色素瘤的启示。
Virchows Arch. 2019 Apr;474(4):421-432. doi: 10.1007/s00428-019-02538-4. Epub 2019 Feb 12.
5
Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases.病毒样颗粒在过敏性疾病预防和免疫治疗中的应用
Allergo J Int. 2018;27(8):245-255. doi: 10.1007/s40629-018-0074-y. Epub 2018 Jul 9.
6
Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System.病毒衣壳衍生的病毒样颗粒(VLPs)与天然免疫系统的相互作用
Vaccines (Basel). 2018 Jul 2;6(3):37. doi: 10.3390/vaccines6030037.
7
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations.癌症中的抗程序性死亡蛋白1(Anti-PD-1)和抗细胞毒性T淋巴细胞相关蛋白4(Anti-CTLA-4)疗法:作用机制、疗效及局限性
Front Oncol. 2018 Mar 28;8:86. doi: 10.3389/fonc.2018.00086. eCollection 2018.
8
Virus-like antigen display for cancer vaccine development, what is the potential?用于癌症疫苗开发的病毒样抗原展示,其潜力如何?
Expert Rev Vaccines. 2018 Apr;17(4):285-288. doi: 10.1080/14760584.2018.1455505. Epub 2018 Mar 30.
9
Virus-like particle display of HER2 induces potent anti-cancer responses.HER2的病毒样颗粒展示诱导强烈的抗癌反应。
Oncoimmunology. 2018 Jan 5;7(3):e1408749. doi: 10.1080/2162402X.2017.1408749. eCollection 2018.
10
A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer .一种靶向癌症干细胞上表达的表位特异性抗xCT的病毒样颗粒免疫疗法可抑制转移性癌症的进展。
Oncoimmunology. 2017 Dec 6;7(3):e1408746. doi: 10.1080/2162402X.2017.1408746. eCollection 2018.